↓ Skip to main content

Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non‐Cancer Pain

Overview of attention for article published in Clinical Pharmacology & Therapeutics, August 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non‐Cancer Pain
Published in
Clinical Pharmacology & Therapeutics, August 2023
DOI 10.1002/cpt.3019
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Lecturer > Senior Lecturer 1 5%
Other 1 5%
Lecturer 1 5%
Student > Bachelor 1 5%
Student > Master 1 5%
Other 1 5%
Unknown 14 70%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 10%
Immunology and Microbiology 1 5%
Social Sciences 1 5%
Medicine and Dentistry 1 5%
Unknown 15 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2025.
All research outputs
#2,278,619
of 32,718,554 outputs
Outputs from Clinical Pharmacology & Therapeutics
#365
of 5,600 outputs
Outputs of similar age
#33,469
of 374,180 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#4
of 50 outputs
Altmetric has tracked 32,718,554 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,600 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,180 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.